Oxitec

Friendly self-limiting mosquitoes — First releases in Djibouti (malaria) and Marshall Islands (dengue), 2026.

Country: United Kingdom

self-limiting-insects eu

Coverage

	CN	EU	US
genome-engineering	✓	✓	✓

Regulatorsepaemamoa-china

Verifiable facts

Fact	Value	Source
Funding	14 prior funding rounds	prospeo.io
Capacity	capacity to generate one billion mosquito eggs per week (UK facility) medium confidence	prnewswire.com
Regulatory approval	regulatory approvals in Brazil (OX513A)	djiboutifriendlymosquito.com
Regulatory approval	U.S. Food and Drug Administration Finding of No Significant Impact (OX513A)	djiboutifriendlymosquito.com
Regulatory approval	positive technical report from National Institute of Public Health and the Environment, Netherlands (OX513A)	djiboutifriendlymosquito.com
Regulatory approval	regulatory approvals from Government of Djibouti for mosquito importation and release (2023)	flyttr.com
Production site	Djibouti facility (mosquito production and research)	flyttr.com · prnewswire.com
Production site	Oxfordshire, UK facility	genewatch.org · prnewswire.com
Headcount	estimated range of 85-262 employees medium confidence	prospeo.io
Revenue	estimated annual revenue ranging from $4.17M to $40.6M medium confidence	prospeo.io

Independent sources: djiboutifriendlymosquito.com · flyttr.com · genewatch.org · prnewswire.com · prospeo.io

Technologies

Name	Cluster	Risk
Ecological engineering & gene drives	genome-engineering	High	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.